| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,697 |
7,019 |
$544K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,407 |
2,283 |
$219K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,494 |
2,127 |
$218K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,541 |
4,279 |
$178K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
975 |
927 |
$89K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,172 |
2,070 |
$69K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
497 |
469 |
$50K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
513 |
397 |
$32K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
523 |
477 |
$19K |
| 92567 |
|
1,278 |
1,131 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,224 |
1,146 |
$12K |
| 94760 |
|
4,906 |
3,934 |
$12K |
| 36416 |
|
1,485 |
1,401 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
68 |
68 |
$6K |
| 99058 |
|
338 |
301 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
396 |
370 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
205 |
189 |
$5K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
47 |
45 |
$4K |
| 87807 |
|
469 |
425 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
217 |
181 |
$3K |
| 85018 |
|
1,059 |
996 |
$2K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
56 |
53 |
$1K |
| J7633 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram |
54 |
53 |
$948.60 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
270 |
234 |
$491.54 |
| A7015 |
Aerosol mask, used with dme nebulizer |
271 |
232 |
$354.10 |
| 94664 |
|
21 |
18 |
$190.85 |
| 81002 |
|
30 |
27 |
$83.44 |
| 96127 |
|
12 |
12 |
$43.74 |
| J7610 |
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
30 |
27 |
$31.98 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
99 |
86 |
$26.02 |
| 99000 |
|
1,386 |
1,277 |
$0.37 |
| 90671 |
|
240 |
234 |
$0.00 |
| 90670 |
|
903 |
862 |
$0.00 |
| 90633 |
|
220 |
213 |
$0.00 |
| 90700 |
|
200 |
187 |
$0.00 |
| 90648 |
|
18 |
16 |
$0.00 |
| 90713 |
|
15 |
15 |
$0.00 |
| 90685 |
|
21 |
20 |
$0.00 |
| 90734 |
|
12 |
12 |
$0.00 |
| 90686 |
|
1,018 |
972 |
$0.00 |
| 90680 |
|
477 |
459 |
$0.00 |
| 90698 |
|
550 |
532 |
$0.00 |
| 90651 |
|
43 |
43 |
$0.00 |
| 90744 |
|
233 |
218 |
$0.00 |
| 97802 |
|
38 |
35 |
$0.00 |